Aspira Women's Health, Inc. (AWHL)
0.2436
+0.01
(+2.44%)
USD |
OTCM |
Oct 05, 16:00
Aspira Women's Health Cash from Investing (Quarterly) : -0.15M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.15M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | -0.008M |
| September 30, 2025 | -0.393M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | -0.002M |
| June 30, 2024 | -0.015M |
| March 31, 2024 | -0.02M |
| December 31, 2023 | -0.012M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.004M |
| March 31, 2023 | -0.008M |
| December 31, 2022 | -0.074M |
| September 30, 2022 | -0.053M |
| June 30, 2022 | -0.023M |
| March 31, 2022 | -0.082M |
| December 31, 2021 | -0.03M |
| September 30, 2021 | -0.018M |
| June 30, 2021 | -0.095M |
| March 31, 2021 | -0.041M |
| December 31, 2020 | -0.223M |
| September 30, 2020 | -0.144M |
| June 30, 2020 | -0.10M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.023M |
| December 31, 2019 | -0.011M |
| September 30, 2019 | -0.039M |
| June 30, 2019 | -0.034M |
| March 31, 2019 | -0.048M |
| December 31, 2018 | -0.055M |
| September 30, 2018 | -0.024M |
| June 30, 2018 | -0.01M |
| March 31, 2018 | -0.024M |
| December 31, 2017 | -0.004M |
| September 30, 2017 | -0.013M |
| June 30, 2017 | -0.017M |
| March 31, 2017 | -0.026M |
| December 31, 2016 | -0.021M |
| September 30, 2016 | -0.172M |
| June 30, 2016 | -0.49M |
| March 31, 2016 | -0.578M |
| December 31, 2015 | -0.833M |
| September 30, 2015 | -0.082M |
| June 30, 2015 | -0.103M |
| March 31, 2015 | -0.037M |
| December 31, 2014 | -0.026M |
| September 30, 2014 | -0.149M |
| June 30, 2014 | -0.064M |
| March 31, 2014 | -0.019M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | -25.50M |
| Neogen Corp. | -4.00M |
| QuidelOrtho Corp. | -107.30M |
| VolitionRX Ltd. | -0.0016M |
| Lucid Diagnostics, Inc. | -0.021M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.01M |
| Cash from Financing (Quarterly) | 1.293M |
| Free Cash Flow | -5.113M |
| Free Cash Flow Per Share (Quarterly) | -0.0488 |
| Free Cash Flow to Equity (Quarterly) | -1.004M |
| Free Cash Flow to Firm (Quarterly) | -1.933M |
| Free Cash Flow Yield | -49.42% |